Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews

References

• Centers for Disease Control and Prevention (CDC). Epidemiology of HIV. 2020; [cited 2020 December 14]. Available from: https://www.hiv.uw.edu/go/screening-diagnosis/epidemiology/core-concept/all.
   Google Scholar
• Deeks SG, Overbaugh J, Phillips A, et al. HIV infection. Nat Rev Dis Primers. 2015;1:15035.
   PubMed Web of Science ®Google Scholar
• Ghosn J, Taiwo B, Seedat S, et al. HIV. Lancet. 2018;392(10148):685–697.
   PubMed Web of Science ®Google Scholar
• Cutrell J, Bedimo R. Single-Tablet regimens in the treatment of HIV-1 infection. Fed Pract. 2016;33(Suppl 3):24S–30S.
   PubMedGoogle Scholar
• Department of Health & Human Services. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. 2021; p. 1–454. Available from: https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/whats-new-guidelines
   Google Scholar
• Truong WR, Schafer JJ, Short WR. Once-daily, single-tablet regimens for the treatment of HIV-1 infection. P T. 2015;40(1):44–55.
   PubMedGoogle Scholar
• Rodriguez-Penney AT, Iudicello JE, Riggs PK, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDS. 2013;27(1):5–16.
   PubMed Web of Science ®Google Scholar
• Zhou S, Martin K, Corbett A, et al. Total daily pill burden in HIV-infected patients in the Southern United States. AIDS Patient Care STDS. 2014;28(6):311–317. PMCPMC4180528.
   PubMed Web of Science ®Google Scholar
• Altice F, Evuarherhe O, Shina S, et al. Adherence to HIV treatment regimens: systematic literature review and meta-analysis. Patient Prefer Adherence. 2019;13:475–490.
   PubMed Web of Science ®Google Scholar
• Pantuzza LL, Ceccato M, Silveira MR, et al. Association between medication regimen complexity and pharmacotherapy adherence: a systematic review. Eur J Clin Pharmacol. 2017;73(11):1475–1489.
   PubMed Web of Science ®Google Scholar
• Uthman OA, Oladimeji O, Nduka C. Adherence to antiretroviral therapy among HIV-infected prisoners: a systematic review and meta-analysis. AIDS Care. 2017;29(4):489–497.
   PubMed Web of Science ®Google Scholar
• Diallo M, Adekpedjou R, Ahouada C, et al. Impact of pre-antiretroviral therapy CD4 counts on drug resistance and treatment failure: a systematic review. AIDS Rev. 2020;22(2):78–92.
   PubMed Web of Science ®Google Scholar
• Vannappagari V, Ragone L, Henegar C, et al. Prevalence of pretreatment and acquired HIV-1 mutations associated with resistance to lamivudine or rilpivirine: a systematic review. Antivir Ther. 2019;24(6):393–404.
   PubMed Web of Science ®Google Scholar
• Bhatta M, Nandi S, Dutta N, et al. HIV care among elderly population: systematic review and meta-analysis. AIDS Res Hum Retroviruses. 2020;36(6):475–489.
   PubMed Web of Science ®Google Scholar
• Chou R, Dana T, Grusing S, et al. Screening for HIV infection in asymptomatic, nonpregnant adolescents and adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2019;321(23):2337–2348.
   PubMed Web of Science ®Google Scholar
• Clay PG, Yuet WC, Moecklinghoff CH, et al. A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Res Ther. 2018;15(1):17.
   PubMed Web of Science ®Google Scholar
• Mbunkah HA, Bertagnolio S, Hamers RL, et al. Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact. J Infect Dis. 2020;221(10):1584–1597.
   PubMed Web of Science ®Google Scholar
• Biadgo B, Ambachew S, Abebe M, et al. Gestational diabetes mellitus in HIV-infected pregnant women: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2019;155:107800.
   PubMed Web of Science ®Google Scholar
• Bigna JJ, Nansseu JR, Noubiap JJ. Pulmonary hypertension in the global population of adolescents and adults living with HIV: a systematic review and meta-analysis. Sci Rep. 2019; May 24 9(1):7837.
   PubMedGoogle Scholar
• Bigna JJ, Ndoadoumgue AL, Nansseu JR, et al. Global burden of hypertension among people living with HIV in the era of increased life expectancy: a systematic review and meta-analysis. J Hypertens. 2020;38(9):1659–1668.
   PubMed Web of Science ®Google Scholar
• Dakum P, Kayode GA, Abimiku A, et al. Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus. Medicine. 2019;98(15):e15024.
   PubMed Web of Science ®Google Scholar
• Dawood G, Klop D, Olivier E, et al. Nature and extent of hearing loss in HIV-infected children: a scoping review. Int J Pediatr Otorhinolaryngol. 2020;134:110036.
   PubMed Web of Science ®Google Scholar
• Dorjee K, Choden T, Baxi SM, et al. Risk of cardiovascular disease associated with exposure to abacavir among individuals with HIV: a systematic review and meta-analyses of results from 17 epidemiologic studies. Int J Antimicrob Agents. 2018;52(5):541–553.
   PubMed Web of Science ®Google Scholar
• Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2019;14(1):52.
   PubMed Web of Science ®Google Scholar
• Echecopar-Sabogal J, D’Angelo-Piaggio L, Chaname-Baca DM, et al. Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: a systematic review and meta-analysis. Int J STD AIDS. 2018;29(5):443–452.
   PubMed Web of Science ®Google Scholar
• Ekrikpo UE, Kengne AP, Bello AK, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443.
   PubMed Web of Science ®Google Scholar
• Erqou S, Lodebo BT, Masri A, et al. Cardiac dysfunction among people living with HIV: a systematic review and Meta-Analysis. JACC Heart Fail. 2019;7(2):98–108.
   PubMed Web of Science ®Google Scholar
• Eyawo O, Brockman G, Goldsmith CH, et al. Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis. BMJ Open. 2019;9(9):e025874.
   PubMed Web of Science ®Google Scholar
• Farahani M, Mulinder H, Farahani A, et al. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017;28(7):636–650.
   PubMed Web of Science ®Google Scholar
• Fialho R, Pereira M, Rusted J, et al. Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis. Psychol Health Med. 2017;22(9):1089–1104.
   PubMed Web of Science ®Google Scholar
• Goh SSL, Lai PSM, Tan ATB, et al. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors. Osteoporos Int. 2018;29(3):595–613.
   PubMed Web of Science ®Google Scholar
• Grand M, Bia D, Diaz A. Cardiovascular risk assessment in people living with HIV: a systematic review and meta-analysis of real-life data. Curr HIV Res. 2020;18(1):5–18.
   PubMed Web of Science ®Google Scholar
• Huntingdon B, Muscat DM, de Wit J, et al. Factors associated with erectile dysfunction among men living with HIV: a systematic review. AIDS Care. 2020;32(3):275–285.
   PubMed Web of Science ®Google Scholar
• Ilha T, Comim FV, Copes RM, et al. HIV and vertebral fractures: a systematic review and metanalysis. Sci Rep. 2018;8(1):7838.
   PubMedGoogle Scholar
• King EM, Albert AY, Murray MCM. HIV and amenorrhea: a meta-analysis. AIDS. 2019;33(3):483–491.
   PubMed Web of Science ®Google Scholar
• Masenga SK, Hamooya BM, Nzala S, et al. Patho-immune mechanisms of hypertension in HIV: a systematic and thematic review. Curr Hypertens Rep. 2019;21(7):56.
   PubMed Web of Science ®Google Scholar
• Maurice JB, Patel A, Scott AJ, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection. AIDS. 2017;31(11):1621–1632.
   PubMed Web of Science ®Google Scholar
• Nansseu JR, Bigna JJ, Kaze AD, et al. Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis. Epidemiology. 2018;29(3):431–441.
   PubMed Web of Science ®Google Scholar
• Olawepo JO, Pharr JR, Cross CL, et al. Changes in body mass index among people living with HIV who are new on highly active antiretroviral therapy: a systematic review and meta-analysis. AIDS Care. 2021;33(3):326–336.
   PubMed Web of Science ®Google Scholar
• Oliveira VHF, Borsari AL, Webel AR, et al. Sarcopenia in people living with the human immunodeficiency virus: a systematic review and meta-analysis. Eur J Clin Nutr. 2020;74(7):1009–1021.
   PubMed Web of Science ®Google Scholar
• Park J, Zuniga JA. Chronic kidney disease in persons living with HIV: a systematic review. J Assoc Nurses AIDS Care. 2018;29(5):655–666.
   PubMed Web of Science ®Google Scholar
• Pires LB, Rocha R, Vargas D, et al. Non-alcoholic fatty liver disease in patients infected with human immunodeficiency virus: a systematic review. Rev Assoc Med Bras. 2020;66(1):81–86.
   PubMed Web of Science ®Google Scholar
• Premkumar A, Dude AM, Haddad LB, et al. Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: a systematic review. Pregnancy Hypertens. 2019;17:178–190.
   PubMed Web of Science ®Google Scholar
• Rao SG, Galaviz KI, Gay HC, et al. Factors associated with excess myocardial infarction risk in HIV-infected adults: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2019;81(2):224–230.
   PubMed Web of Science ®Google Scholar
• Rezaei S, Ahmadi S, Rahmati J, et al. Global prevalence of depression in HIV/AIDS: a systematic review and meta-analysis. BMJ Support Palliat Care. 2019;9(4):404–412.
   PubMed Web of Science ®Google Scholar
• Shah ASV, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and Meta-Analysis. Circulation. 2018;138(11):1100–1112.
   PubMed Web of Science ®Google Scholar
• Soepnel LM, Norris SA, Schrier VJ, et al. The association between HIV, antiretroviral therapy, and gestational diabetes mellitus. AIDS. 2017;31(1):113–125.
   PubMed Web of Science ®Google Scholar
• Tao J, Vermund SH, Qian HZ. Association between depression and antiretroviral therapy use among people living with HIV: a meta-analysis. AIDS Behav. 2018;22(5):1542–1550.
   PubMed Web of Science ®Google Scholar
• Tsegay L, Ayano G. The prevalence of suicidal ideation and attempt among young people with HIV/AIDS: a systematic review and meta-analysis. Psychiatr Q. 2020;91(4):1291–1304.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Mugisha J, De Hert M, et al. Sedentary behavior in people living with HIV: a systematic review and meta-analysis. J Phys Act Health. 2017;14(7):571–577.
   PubMed Web of Science ®Google Scholar
• Ward T, Sugrue D, Hayward O, et al. Estimating HIV management and comorbidity costs among aging HIV patients in the United States: a systematic review. J Manag Care Spec Pharm. 2020;26(2):104–116.
   PubMed Web of Science ®Google Scholar
• Xiao L, Qi H, Wang YY, et al. The prevalence of depression in men who have sex with men (MSM) living with HIV: a meta-analysis of comparative and epidemiological studies. Gen Hosp Psychiatry. 2020;66:112–119.
   PubMed Web of Science ®Google Scholar
• Xu Y, Chen X, Wang K. Global prevalence of hypertension among people living with HIV: a systematic review and meta-analysis. J Am Soc Hypertens. 2017;11(8):530–540.
   PubMed Web of Science ®Google Scholar
• Zhu QY, Huang DS, Lv JD, et al. Prevalence of perinatal depression among HIV-positive women: a systematic review and meta-analysis. BMC Psychiatry. 2019;19(1):330. 30
   PubMed Web of Science ®Google Scholar
• Mulè G, Mulè G, Tranchida V, et al. Aortic stiffness in HIV infection with and without antiretroviral therapy. A meta-analysis of observational studies. Art Res. 2020;26(1):13–20.
   Web of Science ®Google Scholar
• Buscher A, Hartman C, Kallen MA, et al. Impact of antiretroviral dosing frequency and pill burden on adherence among newly diagnosed, antiretroviral-naive HIV patients. Int J STD AIDS. 2012;23(5):351–355.
   PubMed Web of Science ®Google Scholar
• Bangsberg DR, Ragland K, Monk A, et al. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV + homeless and marginally housed people. AIDS. 2010;24(18):2835–2840.
   PubMed Web of Science ®Google Scholar
• Benson C, Wang X, Dunn KJ, et al. Antiretroviral adherence, drug resistance, and the impact of social determinants of health in HIV-1 patients in the US. AIDS Behav. 2020;24(12):3562–3573.
   PubMed Web of Science ®Google Scholar
• Geter A, Sutton MY, Armon C, et al. Disparities in viral suppression and medication adherence among women in the USA, 2011–2016. AIDS Behav. 2019;23(11):3015–3023.
   PubMed Web of Science ®Google Scholar
• Cantudo Cuenca M, Cantudo Cuenca M, Blanquez Martínez D, et al. CP-032 prevalence of comorbidities and effect on ART adherence in HIV-infected patients. Eur J Hosp Pharm. 2014;21(Suppl 1):A13.1–A13.
   Google Scholar
• Monroe AK, Rowe TL, Moore RD, et al. Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study. BMC Health Serv Res. 2013;13:488.
   PubMed Web of Science ®Google Scholar
• Gardner EM, Burman WJ, Maravi ME, et al. Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr. 2005;40(3):294–300.
   PubMed Web of Science ®Google Scholar
• Beyrer C, Pozniak A. HIV drug resistance – an emerging threat to epidemic control. N Engl J Med. 2017;377(17):1605–1607.
   PubMed Web of Science ®Google Scholar
• Hurt CB, Sebastian J, Hicks CB, et al. Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009–2012. Clin Infect Dis. 2014;58(3):423–431.
   PubMed Web of Science ®Google Scholar
• Emu B, Fessel J, Schrader S, et al. Phase 3 study of ibalizumab for multidrug-resistant HIV-1. N Engl J Med. 2018;379(7):645–654.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Safreed-Harmon K, Barton SE, et al. Beyond viral suppression of HIV – the new quality of life frontier. BMC Med. 2016;14(1):94.
   PubMed Web of Science ®Google Scholar
• Marcus JL, Leyden WA, Alexeeff SE, et al. Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000–2016. JAMA Netw Open. 2020;3(6):e207954.
   PubMed Web of Science ®Google Scholar
• Mazzitelli M, Branca Isabel P, Muramatsu T, et al. FRAX assessment in people ageing with HIV. HIV Med. 2022;23(1):103–108.
   PubMed Web of Science ®Google Scholar
• Mazzitelli M, Milinkovic A, Pereira B, et al. Polypharmacy and evaluation of anticholinergic risk in a cohort of elderly people living with HIV. AIDS. 2019;33(15):2439–2441.
   PubMed Web of Science ®Google Scholar
• Pereira B, Mazzitelli M, Milinkovic A, et al. Evaluation of a clinic dedicated to people aging with HIV at Chelsea and Westminster Hospital: results of a 10-Year experience. AIDS Res Hum Retroviruses. 2022;38(3):188–197.
   PubMed Web of Science ®Google Scholar
• Pereira B, Mazzitelli M, Milinkovic A, et al. Use of coronary artery calcium scoring to improve cardiovascular risk stratification and guide decisions to start statin therapy in people living with HIV. J Acquir Immune Defic Syndr. 2020;85(1):98–105.
   PubMed Web of Science ®Google Scholar
• Mbhele N, Chimukangara B, Gordon M. HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistance. Int J Antimicrob Agents. 2021;57(5):106343.
   PubMed Web of Science ®Google Scholar
• World Health Organization. HIV Drug Resistance Report. 2021. p. 1–138.
   Google Scholar
• Gunthard HF, Calvez V, Paredes R, et al. Human immunodeficiency virus drug resistance: 2018 recommendations of the international antiviral Society-USA panel. Clin Infect Dis. 2019;68(2):177–187.
   PubMed Web of Science ®Google Scholar
• Erlandson KM, Perez J, Abdo M, et al. Frailty, neurocognitive impairment, or both in predicting poor health outcomes among adults living with human immunodeficiency virus. Clin Infect Dis. 2019;68(1):131–138.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Islam JY, Rosenberg PS, et al. Projected cancer incidence rates and burden of incident cancer cases in HIV-Infected adults in the United States through 2030. Ann Intern Med. 2018;168(12):866–873.
   PubMed Web of Science ®Google Scholar
• Sigel K, Park L, Justice A. HIV and cancer in the veterans health administration system. Semin Oncol. 2019;46(4–5):334–340.
   PubMed Web of Science ®Google Scholar
• Shiels MS, Althoff KN, Pfeiffer RM, et al. HIV infection, immunosuppression, and age at diagnosis of Non-AIDS-Defining cancers. Clin Infect Dis. 2017;64(4):468–475.
   PubMed Web of Science ®Google Scholar
• Bourgi K, Jenkins CA, Rebeiro PF, et al. Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada. J Int AIDS Soc. 2020;23(4):e25484.
   PubMed Web of Science ®Google Scholar
• Chow W, Donga P, Côté-Sergent A, et al. An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus. Curr Med Res Opin. 2020;36(8):1313–1323.
   PubMed Web of Science ®Google Scholar
• Emond B, Rossi C, Côté-Sergent A, et al. Weight change and predictors of weight change among patients initiated on darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide: a real-world retrospective study. J Health Econ Outcomes Res. 2021;8(1):88–98.
   PubMedGoogle Scholar
• Rebeiro PF, Jenkins CA, Bian A, et al. Risk of incident diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with HIV in the US and Canada. Clin Infect Dis. 2020;73(7):e2234–e2242.
   Web of Science ®Google Scholar
• Asundi A, Olson A, Jiang W, et al. 946. Risk factors and metabolic implications of integrase inhibitor associated weight gain. Open Forum Infectious Diseases. 2020;7(Supplement_1):S505–S506.
   Google Scholar
• Ryom L, Lundgren JD, El-Sadr W, et al. Cardiovascular disease and use of contemporary protease inhibitors: the D:A: D international prospective multicohort study. Lancet HIV. 2018;5(6):e291–e300.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). HIV Surveillance Report – Diagnoses of HIV Infection in the United States and Dependent Areas, 2019. 2019. p. 1–123.
   Google Scholar
• Geter A, Sutton MY, Hubbard McCree D. Social and structural determinants of HIV treatment and care among black women living with HIV infection: a systematic review: 2005–2016. AIDS Care. 2018;30(4):409–416.
   PubMed Web of Science ®Google Scholar
• Levy M, Greenberg A, Hart R, et al. High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC. HIV Med. 2017;18(10):724–735.
   PubMed Web of Science ®Google Scholar
• Chu PL, Santos GM, Vu A, et al. Impact of syndemics on people living with HIV/AIDS in San Francisco. Oral abstract presented at the 2012 International AIDS Conference; 2012 Jul 22–27; Washington, DC.
   Google Scholar
• Branas F, Sanchez-Conde M, Carli F, et al. Sex differences in people aging with HIV. J Acquir Immune Defic Syndr. 2020;83(3):284–291.
   PubMed Web of Science ®Google Scholar
• Raghavan A, Rimmelin DE, Fitch KV, et al. Sex differences in select non-communicable HIV-Associated comorbidities: exploring the role of systemic immune activation/inflammation. Curr HIV/AIDS Rep. 2017;14(6):220–228.
   PubMed Web of Science ®Google Scholar
• Pyra MN, Haberer JE, Hasen N, et al. Global implementation of PrEP for HIV prevention: setting expectations for impact. J Int AIDS Soc. 2019;22(8):e25370.
   PubMed Web of Science ®Google Scholar
• Rios A. Fundamental challenges to the development of a preventive HIV vaccine. Curr Opin Virol. 2018;29:26–32.
   PubMed Web of Science ®Google Scholar